MORG1—A Negative Modulator of Renal Lipid Metabolism in Murine Diabetes
Open Access
- 23 December 2021
- journal article
- research article
- Published by MDPI AG in Biomedicines
- Vol. 10 (1) , 30
Abstract
Renal fatty acid (FA) metabolism is severely altered in type 1 and 2 diabetes mellitus (T1DM and T2DM). Increasing evidence suggests that altered lipid metabolism is linked to tubulointerstitial fibrosis (TIF). Our previous work has demonstrated that mice with reduced MORG1 expression, a scaffold protein in HIF and ERK signaling, are protected against TIF in the db/db mouse model. Renal TGF-ß1 expression and EMT-like changes were reduced in mice with single-allele deficiency of MORG1. Given the well-known role of HIF and ERK signaling in metabolic regulation, here we examined whether protection was also associated with a restoration of lipid metabolism. Despite similar features of TIF in T1DM and T2DM, diabetes-associated changes in renal lipid metabolism differ between both diseases. We found that de novo synthesis of FA/cholesterol and β-oxidation were more strongly disrupted in T1DM, whereas pathological fat uptake into tubular cells mediates lipotoxicity in T2DM. Thus, diminished MORG1 expression exerts renoprotection in the diabetic nephropathy by modulating important factors of TIF and lipid dysregulation to a variable extent in T1DM and T2DM. Prospectively, targeting MORG1 appears to be a promising strategy to reduce lipid metabolic alterations in diabetic nephropathy.Keywords
This publication has 76 references indexed in Scilit:
- Transforming growth factor- and the progression of renal diseaseNephrology Dialysis Transplantation, 2013
- Chronic epithelial kidney injury molecule-1 expression causes murine kidney fibrosisJournal of Clinical Investigation, 2013
- Mitogen-Activated Protein (MAP) Kinase Scaffolding Proteins: A RecountInternational Journal of Molecular Sciences, 2013
- Mitochondrial Fission, Fusion, and StressScience, 2012
- The updated biology of hypoxia‐inducible factorThe EMBO Journal, 2012
- The origin of interstitial myofibroblasts in chronic kidney diseasePediatric Nephrology, 2011
- Renal lipid metabolism and lipotoxicityCurrent Opinion in Nephrology and Hypertension, 2010
- New Insights into Epithelial-Mesenchymal Transition in Kidney FibrosisJournal of the American Society of Nephrology, 2010
- The Novel WD-repeat Protein Morg1 Acts as a Molecular Scaffold for Hypoxia-inducible Factor Prolyl Hydroxylase 3 (PHD3)Journal of Biological Chemistry, 2006
- Multiple Metabolic Hits Converge on CD36 as Novel Mediator of Tubular Epithelial Apoptosis in Diabetic NephropathyPLOS Medicine, 2005